Emerging Coumestans in Cancer Therapy With Mechanistic Insights and Clinical Potential

Area of Science:

• Phytochemistry and Cancer Therapeutics
• Molecular Biology and Signaling Pathways

Background:

• Coumestans are natural phytoestrogens with demonstrated anticancer properties against hormone-dependent cancers.
• They modulate critical cellular signaling pathways, including PI3K/AKT, MAPK, NF-κB, and JAK/STAT.
• Current limitations such as poor bioavailability and solubility hinder clinical application.

Purpose of the Study:

• To provide a comprehensive review of the anticancer mechanisms of key coumestan derivatives: coumestrol, wedelolactone, isofraxidin, and psoralidin.
• To explore innovative strategies for enhancing coumestan efficacy.
• To highlight future research directions for clinical translation.

Main Methods:

• Literature review of coumestan derivatives and their anticancer activities.
• Analysis of signaling pathways regulated by coumestans.
• Exploration of synthetic biology, bioinformatics, and artificial intelligence for efficacy enhancement.

Main Results:

• Detailed overview of the anticancer mechanisms of selected coumestan compounds.
• Identification of strategies to overcome pharmacokinetic challenges.
• Discussion of advanced methodologies for improving therapeutic outcomes.

Conclusions:

• Coumestans possess significant therapeutic potential for hormone-induced cancers.
• Overcoming formulation and delivery challenges is key to clinical success.
• Further research focusing on clinical validation and targeted delivery systems is warranted.